The tumor microenvironment within lymphoid organs of CLL patients promotes interaction of the leukemic clone with the stromal niche, antigen and activated-CD4+CD40L+ T lymphocytes [4–7] playing a pivotal role in enabling survival, proliferation and chemoresistance. Here, CD40LG is linked to B-cell chronic lymphocytic leukemia.